Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
29.52
+1.67 (6.00%)
Mar 4, 2026, 4:00 PM EST - Market closed
Roivant Sciences Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Roivant Sciences stock have an average target of 27.56, with a low estimate of 16.5 and a high estimate of 35. The average target predicts a decrease of -6.64% from the current stock price of 29.52.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Roivant Sciences stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $33 → $34 | Strong Buy | Maintains | $33 → $34 | +15.18% | Mar 4, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $26 → $35 | Strong Buy | Maintains | $26 → $35 | +18.56% | Feb 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $26 → $33 | Strong Buy | Maintains | $26 → $33 | +11.79% | Feb 10, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $28 → $30 | Strong Buy | Maintains | $28 → $30 | +1.63% | Feb 9, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $29 → $32 | Buy | Maintains | $29 → $32 | +8.40% | Dec 15, 2025 |
Financial Forecast
Revenue This Year
10.15M
from 29.05M
Decreased by -65.06%
Revenue Next Year
49.32M
from 10.15M
Increased by 385.85%
EPS This Year
-1.23
from -0.24
EPS Next Year
-1.46
from -1.23
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 13.3M | 234.6M | ||||
| Avg | 10.2M | 49.3M | ||||
| Low | 7.5M | 7.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -54.1% | 2,211.1% | ||||
| Avg | -65.1% | 385.8% | ||||
| Low | -74.0% | -22.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -1.11 | -0.84 | ||||
| Avg | -1.23 | -1.46 | ||||
| Low | -1.27 | -1.84 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.